WallStSmart

Docebo Inc (DCBO)vsServiceNow Inc (NOW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

ServiceNow Inc generates 5371% more annual revenue ($13.28B vs $242.69M). DCBO leads profitability with a 15.5% profit margin vs 13.2%. DCBO trades at a lower P/E of 15.1x. DCBO earns a higher WallStSmart Score of 58/100 (C).

DCBO

Buy

58

out of 100

Grade: C

Growth: 8.7Profit: 8.5Value: 8.3Quality: 5.0
Piotroski: 3/9Altman Z: 0.65

NOW

Buy

56

out of 100

Grade: C

Growth: 7.3Profit: 7.0Value: 4.7Quality: 3.8
Piotroski: 1/9Altman Z: 1.65
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DCBOUndervalued (+68.5%)

Margin of Safety

+68.5%

Fair Value

$59.90

Current Price

$18.54

$41.36 discount

UndervaluedFair: $59.90Overvalued
NOWSignificantly Overvalued (-404.2%)

Margin of Safety

-404.2%

Fair Value

$20.44

Current Price

$103.06

$82.62 premium

UndervaluedFair: $20.44Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DCBO4 strengths · Avg: 9.5/10
Return on EquityProfitability
56.9%10/10

Every $100 of equity generates 57 in profit

EPS GrowthGrowth
141.7%10/10

Earnings expanding 141.7% YoY

Debt/EquityHealth
0.0610/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.1x8/10

Attractively priced relative to earnings

NOW3 strengths · Avg: 8.3/10
Market CapQuality
$110.42B9/10

Large-cap with strong market position

Revenue GrowthGrowth
20.7%8/10

Revenue surging 20.7% year-over-year

Free Cash FlowQuality
$2.00B8/10

Generating 2.0B in free cash flow

Areas to Watch

DCBO3 concerns · Avg: 2.7/10
Market CapQuality
$557.21M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
0.652/10

Distress zone — elevated risk

NOW4 concerns · Avg: 3.8/10
Price/BookValuation
8.3x4/10

Trading at 8.3x book value

EPS GrowthGrowth
3.4%4/10

3.4% earnings growth

Altman Z-ScoreHealth
1.654/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : DCBO

The strongest argument for DCBO centers on Return on Equity, EPS Growth, Debt/Equity. Profitability is solid with margins at 15.5% and operating margin at 15.4%. Revenue growth of 10.5% demonstrates continued momentum.

Bull Case : NOW

The strongest argument for NOW centers on Market Cap, Revenue Growth, Free Cash Flow. Revenue growth of 20.7% demonstrates continued momentum. PEG of 1.06 suggests the stock is reasonably priced for its growth.

Bear Case : DCBO

The primary concerns for DCBO are Market Cap, Piotroski F-Score, Altman Z-Score.

Bear Case : NOW

The primary concerns for NOW are Price/Book, EPS Growth, Altman Z-Score. A P/E of 62.7x leaves little room for execution misses.

Key Dynamics to Monitor

DCBO profiles as a mature stock while NOW is a growth play — different risk/reward profiles.

NOW carries more volatility with a beta of 1.02 — expect wider price swings.

NOW is growing revenue faster at 20.7% — sustainability is the question.

NOW generates stronger free cash flow (2.0B), providing more financial flexibility.

Bottom Line

DCBO scores higher overall (58/100 vs 56/100), backed by strong 15.5% margins and 10.5% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Docebo Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Docebo Inc. provides a cloud-based learning management system to train internal and external workforce, partners, and customers in North America, Europe, and the Asia-Pacific region. The company is headquartered in Toronto, Canada.

Visit Website →

ServiceNow Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

ServiceNow is an American software company based in Santa Clara, California that develops a cloud computing platform to help companies manage digital workflows for enterprise operations.

Want to dig deeper into these stocks?